Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs)

This section outlines the eligibility criteria for applicants, focusing on the types of entities and geographical areas that can participate, along with the overarching objectives for funding advanced combined ATMPs. The program aims to empower healthcare providers, developers, and manufacturers, ultimately benefiting patients across Europe and beyond.

This section details the types of projects and activities eligible for funding, focusing on advanced-stage clinical development of combined Advanced Therapy Medicinal Products (ATMPs) across various health-related sectors.

This section outlines the financial support available, specifying the type of financial instrument and the potential funding amounts for eligible projects focused on combined ATMPs.

This section details key conditions and requirements for applying and participating in the program, including application stipulations, consortium formation, and other important provisions relevant to clinical trials of combined ATMPs.

This section outlines the process for submitting proposals and the subsequent evaluation and selection of projects for funding, specifically for clinical trials of combined ATMPs.

This section identifies the foundational legal and regulatory frameworks that govern the "Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs)" funding program, ensuring transparency and proper governance.